ESC Professional Premium Access

The relationship between changes of antithrombotic drug regimen after ischemic stroke and risks of clinical outcomes in patients with atrial fibrillation

Congress Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
4 presentations
0 follower

3 more presentations in this session

Stroke, mortality, and major bleeding among patients with atrial fibrillation and chronic kidney disease; insights from a contemporary large-scale population study

Speaker: Doctor Y. Ben Baruch Golan (Beer Sheva, IL)

Thumbnail

Kidney function by creatinine and cystatin c and adverse cardiovascular outcomes in patients with atrial fibrillation

Speaker: Mr A. Schweigler (Basel, CH)

Thumbnail

Neurofilament light chain (NFL) - a neuron-specific plasma biomarker for evaluating risk of ischemic cerebral events in atrial fibrillation

Speaker: Doctor J. Aulin (Uppsala, SE)

Thumbnail

Access the full session

Atrial fibrillation and stroke: role of kidney disease and biomarkers

Speakers: Doctor T. Chao, Doctor Y. Ben Baruch Golan, Mr A. Schweigler, Doctor J. Aulin
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by